Navigation Links
Merriman Capital Announces Sponsorship of Radient Pharmaceuticals Corporation on OTCQX
Date:6/23/2011

SAN FRANCISCO, June 23, 2011 /PRNewswire/ -- Merriman Capital, Inc., a wholly owned subsidiary of Merriman Holdings, Inc. (NASDAQ: MERR), today announced that it will serve as the Designated Advisor for Disclosure (DAD) for Radient Pharmaceuticals Corporation (OTCQX: RXPC) as it transitions from trading on the NYSE Amex and begins trading on OTCQX®.

(Logo: http://photos.prnewswire.com/prnh/20100914/SF64919LOGO)    

Radient Pharmaceuticals is dedicated to saving lives and money for patients and global healthcare systems through the deployment of its FDA-cleared Onko-Sure® cancer test kit for colorectal cancer treatment and recurrence monitoring.  After previously trading on NYSE Amex, the Company announced today that it is now trading on the OTC market's highest tier, OTCQX.  

In making this transition, Radient Pharmaceuticals joins a growing list of companies that have chosen to move off a U.S. exchange and onto OTCQX.  In doing so, the Company and its investors will continue to benefit from a compliance-driven, full-service trading platform that is more efficient and cost-effective than a traditional exchange listing.

OTCQX distinguishes the best companies traded over-the-counter (OTC) from more than 9,000 securities traded on the OTCBB and OTC Link that are not required to meet any financial standards or undergo a qualitative review.

Spencer Grimes, Merriman Capital Managing Director, said: "We are very pleased to be partnering with Radient Pharmaceuticals on their transition to OTCQX.  The decision to be quoted on the more cost effective and efficient OTCQX platform is in their shareholders' best interest and will allow management to stay focused on their core business.  I have no doubt that many more companies will be following Rad
'/>"/>

SOURCE Merriman Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Merriman Curhan Ford Acted as Financial Advisor to TorreyPines Therapeutics, Inc. in the Completed Merger With Raptor Pharmaceuticals Corp.
2. Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives
3. DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009
4. Pharmacyclics to Present at Merriman Curhan Fords Investor Summit 2009
5. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
6. Replidyne to Participate on Anti-infective Panel at RBC Capital Markets Healthcare Conference
7. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
8. Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials
9. Foundation Venture Capital Group Invests in UMDNJ Company Working to Improve Leukemia Treatments
10. BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available
11. Atlanta-based Med Tech Company CardioMEMS Raises Additional Capital to Advance its CHAMPION Clinical Trial for its Wireless Sensor System for Heart Failure Monitoring
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... -- ViaCyte, Inc., a privately-held regenerative medicine company with the first stem ... trials, today announced the opening of a second site in its ... T olerability, and E fficacy of VC-01™ Combination P ... is the first in Canada , will be ... , Alberta.  The lead Edmonton ...
(Date:7/29/2015)... Innovations Corp. (DRIO), today announced that its Dario™ Diabetes Management ... Australia .  The Dario was recently launched ... approval in that country. 9 News presented ... As a case in point, the news segment presented how ... old boy with Type 1 diabetes and his mother. As ...
(Date:7/29/2015)... , July 29, 2015  Fifty groups representing ... Wednesday, July 29, to launch the AllTrials campaign in ... trial, past, present, and future, to be registered and ... co-founder Dr Ben Goldacre explains: "Patients want ... good quality evidence on what works. Unfortunately, we now ...
Breaking Medicine Technology:ViaCyte Announces Second Clinical Trial Site at University of Alberta 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 3ViaCyte Announces Second Clinical Trial Site at University of Alberta 4LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 2LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 3Fixing Your Medicine: AllTrials Campaign Launches in US 2Fixing Your Medicine: AllTrials Campaign Launches in US 3
... Texas , May 3 US ... today launched new flexible offerings that can be customized ... practices. Through these expanded offerings, physicians can join more ... of US Oncology to work together to realign ...
... May 3 MAQUET Cardiovascular LLC today ... of the new VASOSHIELD Pressure Controlling Syringe for use ... syringe limits internal "flushing" pressure and controls vessel distension ... in bypass surgery. Avoiding excessive pressure and limiting distension ...
Cached Medicine Technology:US Oncology Launches New Flexible Options for Community Oncologists to Join the United Network of US Oncology 2US Oncology Launches New Flexible Options for Community Oncologists to Join the United Network of US Oncology 3US Oncology Launches New Flexible Options for Community Oncologists to Join the United Network of US Oncology 4MAQUET Cardiovascular Introduces New VASOSHIELD Pressure Controlling Syringe to Help Preserve Graft Integrity for Coronary Artery Bypass Surgery Patients 2MAQUET Cardiovascular Introduces New VASOSHIELD Pressure Controlling Syringe to Help Preserve Graft Integrity for Coronary Artery Bypass Surgery Patients 3MAQUET Cardiovascular Introduces New VASOSHIELD Pressure Controlling Syringe to Help Preserve Graft Integrity for Coronary Artery Bypass Surgery Patients 4
(Date:7/29/2015)... ... July 29, 2015 , ... Today marks a significant achievement in bringing new ... companies and is led by a group of experienced investors, has tapped into an ... their dollars to be a part of the fund. The Sofia Fund II ...
(Date:7/29/2015)... Angeles, CA (PRWEB) , ... July 29, 2015 , ... We are privileged to announce ... Keck Medicine of USC as the ninth best ophthalmology hospital in the nation for 2015-2016. ... top 10 American hospitals for ophthalmology. , “It is an honor to be included ...
(Date:7/29/2015)... ... 2015 , ... Fastline Publications, Inc., will be featured in ... Fastline is dedicated to quality agricultural advertising, both in print and online. In ... searchable agriculture equipment database in the world. The site has equipment listings worth ...
(Date:7/29/2015)... ... July 29, 2015 , ... Inspired ... Foundation in March, Steven W. Meier M.D., a prominent orthopedic surgeon and regenerative ... patients with demonstrated financial need. , “We are thrilled for this opportunity to ...
(Date:7/29/2015)... ... July 29, 2015 , ... It is unique for ... is a tremendous model of care. One that is very hands on and resident ... director of Monarch Landing. “She’s bringing great passion and energy, as well as a ...
Breaking Medicine News(10 mins):Health News:Sofia Fund Surpasses Investor Goals 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3Health News:Fastline Publications to Partner with American Farmer in Upcoming Episode Airing on RFD-TV 2Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2Health News:New Medical Director Readies To Take Reins at Monarch Landing 2Health News:New Medical Director Readies To Take Reins at Monarch Landing 3
... Chicago, IL (June 24, 2008) The American Academy of ... asking 1,000 women their opinions on medical spas. Findings ... the primary customers of these facilities. Yet half of ... supervised medspa facility. , Women ages 18-34 were more ...
... California Hospital Leverages Federal Rule Changes ... Fund Innovative IT Tools, CHICAGO, June 24 ... information solutions that physicians use,to improve healthcare, announced ... of Hoag Memorial Hospital Presbyterian in Newport Beach,Calif. ...
... FORT LAUDERDALE, Fla., June 24 Synovics,Pharmaceuticals, ... company, today announced that its wholly owned ... a leading pharmaceutical,company for the manufacturing and ... annual sales by ANDAPharm with this product, ...
... a "fashion phenomenon" where drinkers are copying their associates, behaviour, ... Durham University,s Institute of Advanced Study and Volterra Consulting UK ... spread of the rapid consumption of large amounts of alcohol ... and criminal behaviour. , Researchers say the findings have ...
... PriceAdvisor Combats Ineffective Pricing Transparency, to Increase Patient Satisfaction & ... ... for Hospitals, VERNON HILLS, Ill. and ... Trintech (Nasdaq: TTPA ) and a leading,provider of contract ...
... Report Abusing Prescription Medications Get ... Relative or Friend, NEW YORK, June 24 A ... and secure, yet it is here that teens are,prone to ... teen,prescription drug misuse and abuse, the Partnership for a Drug-Free,America(R) ...
Cached Medicine News:Health News:Hoag Memorial Hospital Presbyterian Selects Allscripts for Electronic Health Record Subsidy Program 2Health News:Hoag Memorial Hospital Presbyterian Selects Allscripts for Electronic Health Record Subsidy Program 3Health News:Synovics Pharmaceuticals Announces Execution of Hormonal Manufacture and Supply Contract 2Health News:Synovics Pharmaceuticals Announces Execution of Hormonal Manufacture and Supply Contract 3Health News:Synovics Pharmaceuticals Announces Execution of Hormonal Manufacture and Supply Contract 4Health News:Synovics Pharmaceuticals Announces Execution of Hormonal Manufacture and Supply Contract 5Health News:Binge drinking due to 'copying' behavior 2Health News:Concuity Announces the Availability of PriceAdvisor 2Health News:Concuity Announces the Availability of PriceAdvisor 3Health News:Concuity Announces the Availability of PriceAdvisor 4Health News:Abbott and Partnership for a Drug-Free America Launch 'Not In My House' to Help Parents Secure Their Homes from Teen Prescription Drug Misuse and Abuse 2Health News:Abbott and Partnership for a Drug-Free America Launch 'Not In My House' to Help Parents Secure Their Homes from Teen Prescription Drug Misuse and Abuse 3
The RX HERCULINK® PLUS Biliary Stent System is Guidant's high performance .014" guide wire compatible system. It is available in stent diameters of 4.0-6.5mm for the 12mm stent length and 4.0-7.0...
... a supportive .035" guide wire compatible stent system available ... of 18 mm, 28 mm, 38 mm and 58 ... 12 and 16 mm lengths. The 4.0 mm ... "diameter specific" OMNILINK® stents were developed - one in ...
... Supreme and Response catheters comprise the ... available for electrophysiology procedures. Their advanced ... for superior torque response with a ... curves and French sizes, Supreme and ...
... left heart catheterization occurs when the initial ... sheath with an alternate curve while maintaining ... exchange has required a repeat septal puncture--complex ... overcome this problem with the unique PERRY ...
Medicine Products: